Powered by

-Bachem Holding AG - Fiscal year 2016, another year of strong sales and profit growth

Bubendorf and Basel - Bachem Group (SIX: BANB), the market leader in the field of peptide chemistry with a distinctive focus on quality and innovation, set another sales record in the 2016 fiscal year and reported sharply higher earnings.

Bachem managed to sustain its very good momentum from the first half of the year throughout the second half. The Group generated full-year sales of 236.5 million CHF (2015: 208.6 million CHF, +13.4% in CHF). Bachem increased its operating profit (EBIT) by

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox